HealthEquity, Inc. (NASDAQ:HQY) Expected to Post Quarterly Sales of $202.59 Million

Equities analysts forecast that HealthEquity, Inc. (NASDAQ:HQYGet Rating) will post $202.59 million in sales for the current fiscal quarter, Zacks Investment Research reports. Five analysts have made estimates for HealthEquity’s earnings, with the highest sales estimate coming in at $208.30 million and the lowest estimate coming in at $200.14 million. HealthEquity reported sales of $184.20 million during the same quarter last year, which would suggest a positive year over year growth rate of 10%. The business is expected to issue its next quarterly earnings results on Monday, January 1st.

On average, analysts expect that HealthEquity will report full year sales of $825.14 million for the current fiscal year, with estimates ranging from $821.25 million to $828.12 million. For the next year, analysts anticipate that the business will report sales of $894.93 million, with estimates ranging from $884.50 million to $913.82 million. Zacks Investment Research’s sales averages are an average based on a survey of research firms that cover HealthEquity.

HealthEquity (NASDAQ:HQYGet Rating) last issued its quarterly earnings data on Tuesday, March 22nd. The company reported $0.09 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.09. The firm had revenue of $203.30 million during the quarter, compared to the consensus estimate of $199.27 million. HealthEquity had a positive return on equity of 3.49% and a negative net margin of 5.85%. During the same period in the prior year, the business earned $0.30 EPS.

A number of research analysts recently commented on HQY shares. Deutsche Bank Aktiengesellschaft upped their price objective on HealthEquity from $62.00 to $66.00 and gave the stock a “buy” rating in a research note on Thursday, March 24th. Wells Fargo & Company began coverage on HealthEquity in a research note on Monday, April 11th. They set an “overweight” rating and a $95.00 price objective for the company. Jefferies Financial Group increased their price target on HealthEquity from $62.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, March 28th. Bank of America increased their price target on HealthEquity from $63.00 to $70.00 in a research note on Wednesday, March 23rd. Finally, BTIG Research raised HealthEquity from a “neutral” rating to a “buy” rating and set a $85.00 price target for the company in a research note on Wednesday, March 30th. One analyst has rated the stock with a sell rating, one has issued a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, HealthEquity presently has a consensus rating of “Buy” and an average target price of $77.33.

Several institutional investors have recently made changes to their positions in the company. BlackRock Inc. lifted its holdings in shares of HealthEquity by 0.7% in the fourth quarter. BlackRock Inc. now owns 9,064,265 shares of the company’s stock valued at $401,004,000 after buying an additional 59,190 shares during the period. Wasatch Advisors Inc. lifted its holdings in shares of HealthEquity by 19.3% in the fourth quarter. Wasatch Advisors Inc. now owns 7,394,067 shares of the company’s stock valued at $327,114,000 after buying an additional 1,197,807 shares during the period. William Blair Investment Management LLC lifted its holdings in shares of HealthEquity by 1.1% in the third quarter. William Blair Investment Management LLC now owns 3,769,799 shares of the company’s stock valued at $244,132,000 after buying an additional 42,186 shares during the period. JPMorgan Chase & Co. lifted its holdings in shares of HealthEquity by 29.5% in the fourth quarter. JPMorgan Chase & Co. now owns 2,587,846 shares of the company’s stock valued at $114,487,000 after buying an additional 589,509 shares during the period. Finally, Mackenzie Financial Corp lifted its holdings in shares of HealthEquity by 22.9% in the fourth quarter. Mackenzie Financial Corp now owns 2,267,898 shares of the company’s stock valued at $100,332,000 after buying an additional 422,484 shares during the period. Institutional investors and hedge funds own 96.68% of the company’s stock.

Shares of HQY opened at $70.01 on Monday. The company has a market cap of $5.87 billion, a P/E ratio of -132.09, a PEG ratio of 6.01 and a beta of 1.09. The stock has a fifty day moving average price of $58.99 and a 200 day moving average price of $57.05. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.29 and a quick ratio of 2.29. HealthEquity has a 12 month low of $36.81 and a 12 month high of $84.78.

HealthEquity Company Profile (Get Rating)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Further Reading

Get a free copy of the Zacks research report on HealthEquity (HQY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.